세포 치료 시장

The cell therapy market is anticipated to grow from US$ 10.28 billion in 2024 to US$ 16.72 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.2% during the period from 2031 to 2031. Key trends driving this market include advancements in cell-based therapeutics and the launch of innovative products by leading manufacturers.

Analysis of the Cell Therapy Market

Regenerative therapies promote the regeneration of cells, tissues, and organs, facilitating the restoration of their functions. As reported by the Alliance for Regenerative Medicine, there were 520 clinical trials involving cell therapy medicines globally as of Q4 2023 (comprising 192 Phase I, 125 Phase II, and 36 Phase III trials). The approval and commercialization of Kymriah in 2017, the first of its kind in cell therapy, marked a pivotal moment that has bolstered the significance of cell therapy within the cell and gene therapy sector. The advent of CAR-T cell (chimeric antigen receptor T cell) therapy has revolutionized cancer treatment approaches. CAR-T cell therapies have seen extensive research and innovation, with five additional products-Yescarta, Abecma, Tecartus, Breyanzi, and Carvykti-receiving approval for various blood cancers. Consequently, the expanding applications of regenerative medicine are propelling the growth of the cell therapy market.

Overview of the Cell Therapy Market

CAR T-cell therapy has emerged as a promising cancer treatment modality. Each year, numerous preclinical and clinical trials are conducted to explore its potential in new therapeutic applications. Future research is expected to focus on both autologous and allogeneic products, as well as new in-vivo CAR-T cell gene therapies and their effectiveness in conditions beyond hematologic malignancies.

Strategic Insights

Drivers and Opportunities in the Cell Therapy Market

Rising Cancer Prevalence Fuels Market Expansion

Factors such as sedentary lifestyles and dietary changes are recognized as significant risk factors for chronic diseases, including neurological disorders, cancer, autoimmune diseases, and cardiovascular diseases. The Centers for Disease Control and Prevention reports that 6 out of 10 Americans are affected by one or more chronic illnesses, including diabetes, cancer, heart disease, or stroke. Chronic diseases are leading causes of death and disability in the US. Factors like genetic predisposition, processed foods, pollution, and lifestyle changes contribute to the increasing incidence of cancer. The American Cancer Society noted nearly 19.3 million new cancer cases worldwide in 2020. In recent decades, cell therapy has emerged as a novel cancer treatment approach, where T cells are modified in a lab and then administered to target cancer cells. CAR-T cell therapy is utilized for treating adult and pediatric leukemia and certain types of lymphoma, with ongoing research into its potential for treating other cancers, including solid tumors. Thus, the rising number of cancer patients is driving demand for CAR-T cell therapies, contributing to the growth of the cell therapy market.

Funding for Research and Development

Researchers are driven to explore ways to enhance the efficacy of cell therapy, particularly given the complete response rates and progression-free survival seen in patients with relapsed/refractory malignancies who have undergone prior treatments. Investigations into factors like antigen loss that may lead to immune escape are underway, with strategies being developed to address these challenges. One promising approach involves designing cell therapies that target multiple antigens simultaneously. The California Institute for Regenerative Medicine (CIRM), the largest regenerative medicine organization globally, has allocated US$ 43.8 million to support gene therapy and stem cell research initiatives in California, funding projects across clinical, discovery, and infrastructure programs of the institute.

Segmentation Analysis of the Cell Therapy Market

Key segments contributing to the analysis of the cell therapy market include therapy type, product, technology, application, and end user.

• The cell therapy market is categorized by therapy type into allogeneic and autologous, with the allogeneic segment holding a larger market share in 2023.
• By product, the market is divided into consumables, equipment, and systems and software, with the equipment segment leading the market share in 2023.
• In terms of technology, the market encompasses viral vector technology, genome editing technology, somatic cell technology, cell immortalization technology, cell plasticity technology, and three-dimensional technology.
• By application, the market is segmented into oncology, cardiovascular, orthopedic, wound management, and other applications, with oncology holding the largest market share in 2023.
• Based on end user, the cell therapy market is classified into research institutes, hospitals, and others, with hospitals dominating the market share in 2023.

Geographical Analysis of the Cell Therapy Market

The geographical scope of the cell therapy market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America leads the market, with the US holding the largest share in 2023. This growth is attributed to increased research and development, along with the rising adoption of cell therapies such as stem cell, gene, and immune therapies. The growing incidence of genetic and cellular disorders, coupled with a focus on enhancing the development and manufacturing capacities of cell therapies, further supports market growth. Bayer AG has established its first Cell Therapy Launch Facility in Berkeley, aimed at delivering cell therapies to patients globally. This US$ 250 million, 100,000-square-foot facility will provide materials for late-stage clinical trials to facilitate the commercial launch of bemdaneprocel (BRT-DA01), an experimental cell therapy being tested by BlueRock Therapeutics for Parkinson's disease and other conditions. The Asia Pacific region is expected to exhibit the highest CAGR in the cell therapy market during the forecast period.

Scope of the Cell Therapy Market Report

Recent Developments in the Cell Therapy Market

The evaluation of the cell therapy market is based on qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Some recent developments in the cell therapy market include:

• Ginkgo Bioworks, a company focused on building a leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics' cell therapy platform assets, which include their CAR and switch receptor libraries. (Source: Ginkgo Bioworks Company Name, Press Release, 2024)
• AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company that develops innovative cell therapies for cancer and autoimmune diseases. (Source: AstraZeneca Company Name, Press ReleaseNewsletter, 2024)

Coverage and Deliverables of the Cell Therapy Market Report

The report titled "Cell Therapy Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

• Cell therapy market size and forecast at global, regional, and country levels for all key market segments included in the scope.
• Trends in the cell therapy market along with market dynamics such as drivers, restraints, and key opportunities.
• In-depth PEST/Porter's Five Forces and SWOT analysis.
• Analysis of the cell therapy market covering key trends, global and regional frameworks, major players, regulations, and recent market developments.
• Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments in the cell therapy market.
• Detailed profiles of key companies in the market.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 Global Cell Therapy Market and By Therapy Type
  • 1.3.2 Global Cell Therapy Market and By Product
  • 1.3.3 Global Cell Therapy Market and By Technology
  • 1.3.4 Global Cell Therapy Market and By Application
  • 1.3.5 Global Cell Therapy Market and By End User
  • 1.3.6 Global Cell Therapy Market and By Geography

2. Cell Therapy Market and Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Global Cell therapyand Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 North America and PEST Analysis
  • 4.2.2 Europeand PEST Analysis
  • 4.2.3 Asia Pacificand PEST Analysis
  • 4.2.4 Middle East and Africa and PEST Analysis
  • 4.2.5 South and Central America and PEST Analysis
• 4.3 Expert Opinions

5. Global Cell Therapy Market and Key Industry Dynamics

• 5.1 Key Market Drivers
  • 5.1.1 Increasing Prevalence of Chronic Diseases
  • 5.1.2 Rising Adoption of Regenerative Medicines
  • 5.1.3 Increasing Number of Approvals for Cell-Based Therapies
• 5.2 Key Market Restraints
  • 5.2.1 High Cost of Cell Therapy Manufacturing
• 5.3 Key Market Opportunities
  • 5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
• 5.4 Future Trends
  • 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
• 5.5 Impact Analysis of Drivers and Restraints

6. Cell therapy Market and Global Analysis

• 6.1 Global Cell therapy Market Revenue Forecast And Analysis
• 6.2 Global Cell therapy Market, By Geography - Forecast And Analysis
• 6.3 Market Positioning

7. Cell therapy Market Analysis and By Therapy Type

• 7.1 Overview
• 7.2 Cell therapy Market Revenue Share, by Therapy Type (2024 and 2031)
• 7.3 Allogeneic
  • 7.3.1 Overview
  • 7.3.2 Allogeneic: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 7.4 Autologous
  • 7.4.1 Overview
  • 7.4.2 Autologous: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

8. Cell therapy Market Analysis and By Product

• 8.1 Overview
• 8.2 Cell therapy Market Revenue Share, by Product (2024 and 2031)
• 8.3 Consumables
  • 8.3.1 Overview
  • 8.3.2 Consumables: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 8.4 Equipment
  • 8.4.1 Overview
  • 8.4.2 Equipment: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 8.5 Systems and Software
  • 8.5.1 Overview
  • 8.5.2 Systems and Software: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

9. Cell therapy Market Analysis and By Technology

• 9.1 Overview
• 9.2 Cell therapy Market Revenue Share, by Technology (2024 and 2031)
• 9.3 Viral Vector Technology
  • 9.3.1 Overview
  • 9.3.2 Viral Vector Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 9.4 Genome Editing Technology
  • 9.4.1 Overview
  • 9.4.2 Genome Editing Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 9.5 Somatic Cell Technology
  • 9.5.1 Overview
  • 9.5.2 Somatic Cell Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 9.6 Cell Immortalization Technology
  • 9.6.1 Overview
  • 9.6.2 Cell Immortalization Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 9.7 Cell Plasticity Technology
  • 9.7.1 Overview
  • 9.7.2 Cell Plasticity Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 9.8 Three-Dimensional Technology
  • 9.8.1 Overview
  • 9.8.2 Three-Dimensional Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

10. Cell therapy Market Analysis and By Application

• 10.1 Overview
• 10.2 Cell therapy Market Revenue Share, by Application (2024 and 2031)
• 10.3 Oncology
  • 10.3.1 Overview
  • 10.3.2 Oncology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 10.4 Cardiovascular
  • 10.4.1 Overview
  • 10.4.2 Cardiovascular: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 10.5 Orthopedic
  • 10.5.1 Overview
  • 10.5.2 Orthopedic: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 10.6 Wound Management
  • 10.6.1 Overview
  • 10.6.2 Wound Management: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 10.7 Other Applications
  • 10.7.1 Overview
  • 10.7.2 Other Applications: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

11. Cell therapy Market Analysis and By End User

• 11.1 Overview
• 11.2 Cell therapy Market Share, by End User, 2024 and 2031, (%)
• 11.3 Hospitals
  • 11.3.1 Overview
  • 11.3.2 Hospitals: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 11.4 Research Institutes
  • 11.4.1 Overview
  • 11.4.2 Research Institutes: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
• 11.5 Others
  • 11.5.1 Overview
  • 11.5.2 Others: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

12. Cell therapy Market and Geographic Analysis

• 12.1 North America: Cell Therapy Market
  • 12.1.1 Overview
  • 12.1.2 North America: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
  • 12.1.3 North America: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
  • 12.1.4 North America: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
  • 12.1.5 North America: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
  • 12.1.6 North America: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
  • 12.1.7 North America: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.1.8 North America: Cell Therapy Market, by Country, 2024 and 2031 (%)
  • 12.1.9 US: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.9.1 US: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.9.2 US: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.1.9.3 US: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.1.9.4 US: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.1.9.5 US: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.1.9.6 US: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.1.10 Canada: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10.1 Canada: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10.2 Canada: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10.3 Canada: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10.4 Canada: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10.5 Canada: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10.6 Canada: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.1.11 Mexico: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11.1 Mexico: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11.3 Mexico: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11.4 Mexico: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11.5 Mexico: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11.6 Mexico: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
• 12.2 Europe: Cell therapy Market
  • 12.2.1 Overview
  • 12.2.2 Europe: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
  • 12.2.3 Europe: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
  • 12.2.4 Europe: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
  • 12.2.5 Europe: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
  • 12.2.6 Europe: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
  • 12.2.7 Europe: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2.8 Europe: Cell therapy Market, by Country, 2024 and 2031 (%)
  • 12.2.9 Germany: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.9.1 Germany: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.9.2 Germany: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.9.3 Germany: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.9.4 Germany: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.9.5 Germany: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.9.6 Germany: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2.10 France: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10.1 France: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10.2 France: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10.3 France: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10.4 France: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10.5 France: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10.6 France: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2.11 UK: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11.1 UK: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11.2 UK: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11.3 UK: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11.4 UK: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11.5 UK: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11.6 UK: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2.12 Italy: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12.1 Italy: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12.2 Italy: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12.3 Italy: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12.4 Italy: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12.5 Italy: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12.6 Italy: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2.13 Spain: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13.1 Spain: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13.2 Spain: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13.3 Spain: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13.4 Spain: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13.5 Spain: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13.6 Spain: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
• 12.3 Asia Pacific: Cell Therapy Market
  • 12.3.1 Overview
  • 12.3.2 Asia Pacific: Cell Therapy Market - Revenue and Forecast to 2031 (USD Million)
  • 12.3.3 Asia Pacific: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
  • 12.3.4 Asia Pacific: Cell Therapy Market, by Product, 2018and2031 (USD Million)
  • 12.3.5 Asia Pacific: Cell Therapy Market, by Technology 2018and2031 (USD Million)
  • 12.3.6 Asia Pacific: Cell Therapy Market, by Application 2018and2031 (USD Million)
  • 12.3.7 Asia Pacific: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.3.8 Asia Pacific: Cell Therapy Market, by Country, 2024 and 2031 (%)
  • 12.3.9 China: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.9.1 China: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.9.2 China: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.9.3 China: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.9.4 China: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.9.5 China: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.9.6 China: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.3.10 Japan: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.10.1 Japan: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.10.2 Japan: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.10.3 Japan: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.10.4 Japan: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.10.5 Japan: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.10.6 Japan: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.3.11 India: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.11.1 India: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.11.2 India: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.11.3 India: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.11.4 India: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.11.5 India: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.11.6 India: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.3.12 South Korea: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.12.1 South Korea: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.12.2 South Korea: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.12.3 South Korea: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.12.4 South Korea: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.12.5 South Korea: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.12.6 South Korea: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.3.13 Australia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.13.1 Australia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.3.13.2 Australia: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.13.3 Australia: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.13.4 Australia: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.13.5 Australia: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.13.6 Australia: Cell Therapy Market, by End User, 2018and2031 (USD Million)
• 12.4 Middle East and Africa: Cell Therapy Market
  • 12.4.1 Overview
  • 12.4.2 Middle East and Africa: Cell Therapy Market - Revenue and Forecast to 2031 (USD Million)
  • 12.4.3 Middle East and Africa: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
  • 12.4.4 Middle East and Africa: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
  • 12.4.5 Middle East and Africa: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
  • 12.4.6 Middle East and Africa: Cell Therapy Market, by Application, 2018and2031 (USD Million)
  • 12.4.7 Middle East and Africa: Cell Therapy Market, by End-User, 2018and2031 (USD Million)
  • 12.4.8 Middle East and Africa: Cell Therapy Market, by Country, 2019 and 2031 (%)
  • 12.4.9 UAE: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.4.9.1 UAE: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.4.9.2 UAE: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
    • 12.4.9.3 UAE: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
    • 12.4.9.4 UAE: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
    • 12.4.9.5 UAE: Cell Therapy Market, by Application, 2018and2031 (USD Million)
    • 12.4.9.6 UAE: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.4.10 Saudi Arabia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.4.10.1 Saudi Arabia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.4.10.2 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
    • 12.4.10.3 Saudi Arabia: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
    • 12.4.10.4 Saudi Arabia: Cell Therapy Market, by Technology, 2018and2031 (USD Millions)
    • 12.4.10.5 Saudi Arabia: Cell Therapy Market, by Application, 2018and2031 (USD Million)
    • 12.4.10.6 Saudi Arabia: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.4.11 South Africa: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.4.11.1 South Africa: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.4.11.2 South Africa: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
    • 12.4.11.3 South Africa: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.4.11.4 South Africa: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
    • 12.4.11.5 South Africa: Cell Therapy Market, by Application, 2018and2031 (USD Million)
    • 12.4.11.6 South Africa: Cell Therapy Market, by End User, 2018and2031 (USD Million)
• 12.5 South and Central America: Cell Therapy Market
  • 12.5.1 Overview
  • 12.5.2 South and Central America: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
  • 12.5.3 South and Central America: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
  • 12.5.4 South and Central America: Cell Therapy Market, by Product, 2018and2031 (USD Million)
  • 12.5.5 South and Central America: Cell Therapy Market, by Technology 2018and2031 (USD Million)
  • 12.5.6 South and Central America: Cell Therapy Market, by Application 2018and2031 (USD Million)
  • 12.5.7 South and Central America: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.5.8 South and Central America: Cell Therapy Market, by Country, 2024 and 2031 (%)
  • 12.5.9 Brazil: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.5.9.1 Brazil: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.5.9.2 Brazil: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.5.9.3 Brazil: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.5.9.4 Brazil: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.5.9.5 Brazil: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.5.9.6 Brazil: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.5.10 Argentina: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.5.10.1 Argentina: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.5.10.2 Argentina: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.5.10.3 Argentina: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.5.10.4 Argentina: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.5.10.5 Brazil: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.5.10.6 Brazil: Cell Therapy Market, by End User, 2018and2031 (USD Million)

13. Impact of COVID-19 Pandemic on Global Cell Therapy Market

• 13.1 North America: Impact Assessment of COVID-19 Pandemic
• 13.2 Europe: Impact Assessment of COVID-19 Pandemic
• 13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
• 13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
• 13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Cell Therapy Marketand Industry Landscape

• 14.1 Overview
• 14.2 Growth Strategies Done by the Companies in the Market, (%)
• 14.3 Organic Developments
  • 14.3.1 Overview
• 14.4 Inorganic Developments
  • 14.4.1 Overview

15. Company Profiles

• 15.1 Vericel Corporation
  • 15.1.1 Key Facts
  • 15.1.2 Business Description
  • 15.1.3 Products and Services
  • 15.1.4 Financial Overview
  • 15.1.5 SWOT Analysis
  • 15.1.6 Key Developments
• 15.2 MEDIPOST
  • 15.2.1 Key Facts
  • 15.2.2 Business Description
  • 15.2.3 Products and Services
  • 15.2.4 Financial Overview
  • 15.2.5 SWOT Analysis
  • 15.2.6 Key Developments
• 15.3 NuVasive, Inc.
  • 15.3.1 Key Facts
  • 15.3.2 Business Description
  • 15.3.3 Products and Services
  • 15.3.4 Financial Overview
  • 15.3.5 SWOT Analysis
  • 15.3.6 Key Developments
• 15.4 Mesoblast Limited
  • 15.4.1 Key Facts
  • 15.4.2 Business Description
  • 15.4.3 Products and Services
  • 15.4.4 Financial Overview
  • 15.4.5 SWOT Analysis
  • 15.4.6 Key Developments
• 15.5 JCR Pharmaceuticals Co. Ltd.
  • 15.5.1 Key Facts
  • 15.5.2 Business Description
  • 15.5.3 Products and Services
  • 15.5.4 Financial Overview
  • 15.5.5 SWOT Analysis
  • 15.5.6 Key Developments
• 15.6 Smith and Nephew
  • 15.6.1 Key Facts
  • 15.6.2 Business Description
  • 15.6.3 Products and Services
  • 15.6.4 Financial Overview
  • 15.6.5 SWOT Analysis
  • 15.6.6 Key Developments
• 15.7 Bristol-Myers Squibb Company
  • 15.7.1 Key Facts
  • 15.7.2 Business Description
  • 15.7.3 Products and Services
  • 15.7.4 Financial Overview
  • 15.7.5 SWOT Analysis
  • 15.7.6 Key Developments
• 15.8 Cells for Cells
  • 15.8.1 Key Facts
  • 15.8.2 Business Description
  • 15.8.3 Products and Services
  • 15.8.4 Financial Overview
  • 15.8.5 SWOT Analysis
  • 15.8.6 Key Developments
• 15.9 Stemedica Cell Technologies, Inc
  • 15.9.1 Key Facts
  • 15.9.2 Business Description
  • 15.9.3 Products and Services
  • 15.9.4 Financial Overview
  • 15.9.5 SWOT Analysis
  • 15.9.6 Key Developments
• 15.10 Castle Creek Biosciences, Inc.
  • 15.10.1 Key Facts
  • 15.10.2 Business Description
  • 15.10.3 Products and Services
  • 15.10.4 Financial Overview
  • 15.10.5 SWOT Analysis
  • 15.10.6 Key Developments

16. Appendix

• 16.1 About The Insight Partners
• 16.2 Glossary of Terms